Fig. 3From: Granisetron plus aprepitant versus granisetron in preventing nausea and vomiting during CHOP or R-CHOP regimen in malignant lymphoma: a retrospective studyTime to first vomiting and using rescue medication during the overall (0–120 h) phases. The two groups did not show a statistically significant difference in this variable (p = 0.909)Back to article page